Please try another search
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Completed Patterns | |||||
Three Outside Up | 1M | 14 | Oct 19 | ||
Three Outside Up | 1W | 14 | Sep 13, 2020 | ||
Bullish Engulfing | 1M | 15 | Sep 19 | ||
Bullish Engulfing | 1W | 15 | Sep 06, 2020 | ||
Three Outside Down | 1W | 16 | Aug 30, 2020 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
DMCI | 11.360 | 12.160 | 11.360 | -0.840 | -6.89% | 12.66M | 27/03 | ||
Cebu Landmasters | 2.800 | 2.800 | 2.780 | 0.000 | 0.00% | 537.00K | 27/03 | ||
Citicore Energy REIT | 2.79 | 2.81 | 2.79 | 0.00 | 0.00% | 0 | 26/03 | ||
GT Capital | 704.00 | 706.00 | 686.00 | +14.00 | +2.03% | 109.93K | 27/03 | ||
Metropolitan Bank | 65.15 | 65.20 | 64.85 | -0.05 | -0.08% | 2.30M | 27/03 | ||
Semirara Mining | 34.90 | 35.20 | 34.90 | -0.10 | -0.29% | 3.14M | 27/03 | ||
MREIT | 13.00 | 13.00 | 12.82 | +0.02 | +0.15% | 2.34M | 27/03 | ||
LT Group | 9.990 | 9.990 | 9.840 | +0.090 | +0.91% | 2.76M | 27/03 | ||
Ayala Land | 32.250 | 32.550 | 31.800 | +0.200 | +0.62% | 30.79M | 27/03 | ||
AREIT, | 35.20 | 35.50 | 35.10 | -0.30 | -0.85% | 341.50K | 27/03 |
Recipharm AB (publ) operates as a pharmaceutical contract development and manufacturing company in Sweden, the United Kingdom, Italy, Germany, France, India, Spain, Portugal, and internationally. It operates through four segments: Advanced Delivery Systems (ADS), Manufacturing Steriles (MFG-S), Manufacturing Solids & Others (MFG-SO), and Development & Licensing (D&L). The ADS segment develops and manufactures inhalation products and devices, including integrated drug solutions, medical check valves, and injection devices. The MFG-S segment manufactures sterile products using lyophilisation and blow-fillseal technologies. The MFG-SO segment manufactures non-sterile products, such as tablets, capsules, semi-solids, liquids, and powders. The D&L segment provides pharmaceutical development services, including preclinical and formulation development, and clinical trial material services; manages patents, technologies, and drug product rights; and develops and manufactures drug substance. It also offers packaging products comprising bottles, blisters, stick-packs, vials, ampoules, syringes, pouches, and patches; and online vendor managed inventory solutions. The company was founded in 1994 and is headquartered in Stockholm, Sweden.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review